Talent Aortic Cuff Stent Graft System Compassionate Use Registry

The primary purpose of this registry is to provide an endovascular means of treatment for
those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated
stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic
Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an
inadequate seal zone (< 1 cm). For Registry purposes, a Type III endoleak will be defined as
a proximal modular endoleak.

Inclusion Criteria:

- Patient >= 18 years of age

- Patient has a serious disease or condition

- No generally acceptable alternative for treating patient is available

- Patient has had the AneuRx stent graft system implanted >= 30 days

- Patient has suboptimal outcome with the AneuRx stent graft system as evidenced by one
or more of the following:

- Type I endoleak

- Type III endoleak (Proximal, modular)

- Loss of seal zone

- Proximal aortic neck diameter >= 14mm and <= 30mm

- Angle between axis of the suprarenal aorta and aneurysm neck is <= 60 degrees

- Patient is able and willing to be available for 12,24,26,48 and 60 months
post-procedure

Exclusion Criteria:

- Patient is pregnant of lactating

- Arterial access cannot be crossed with a delivery system

- Excessive vessel tortuosity

- Excessive aortic calcification

- AneuRx stent graft system implanted within the last 30 days